Evaluation of 99mTc-labeled ant ...
One of the fields of research in nuclear medicine is the development of new radiopharmaceuticals for imaging infection and inflammation in humans. F ...
Present and future of FDG-PET/C ...
Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian canc ...
Proliferation and differentiati ...
CD34 is the most frequently used marker for the selection of cells for bone marrow (BM) transplantation. The use of CD133 as an alternative marker i ...
F-18 FDG uptake of bone marrow ...
The percentage of myeloma cells in bone marrow is subsequently an important index of disease in patients with multiple myeloma (MM). Bone marrow mye ...
Use of Glubran 2 and Glubran ti ...
Patients with bleeding disorders are at a high risk of bleeding complications during surgical procedures. Cyanoacrylates have been used successfully ...
Concurrent p16 methylation patt ...
Disruption of cell cycle control genes, including p16, is known to contribute to the cancerogenesis of multiple myeloma (MM). We investigated the me ...
Outpatient treatment with intra ...
The purpose of this study was to evaluate outcomes such as success of the initial therapy, failure of outpatient treatment, and death in outpatient ...
Acute but not chronic graft-ver ...
Defects in central and peripheral tolerance are thought to contribute to life-threatening graft-versus-host disease (GvHD), a severe complication fo ...
Synoviorthesis induced by rifam ...
Intra-articular hemorrhage is the clinical hallmark of hemophilia. Synoviorthesis, the intra-articular injection of chemical or radioactive substanc ...
Circulating procoagulant microp ...
Accumulating evidence indicates that microparticles (MPs) are important mediators of the interaction between cancer and the hemostatic system. We co ...
Predictors for splenectomy amon ...
We conducted a nationwide cohort study of adult Danish patients with primary chronic immune thrombocytopenia (cITP) to examine selected patient and ...
FOXP1 expression and its clinic ...
The aims of this study were to investigate FOXP1 expression in nodal and extranodal diffuse large B-cell lymphoma (DLBCL) and its association with t ...
Comparison between oral and int ...
The fludarabine plus cyclophosphamide (FC) regimen was reported to be superior to chlorambucil or fludarabine alone in terms of complete response (C ...
Genotyping of intron 22-related ...
Hemophilia A (HA) is the most common severe bleeding disorder in humans, affecting one in 5,000 male births. In severe HA, intron 22 inversion of F8 ...
Costs of managing severe immune ...
This study aims to report resource utilisation and annual cost for chronic immune thrombocytopenia (ITP) patients enrolled consecutively and followe ...
Efficacy of the combination of ...
Bortezomib–dexamethasone (Btz/Dex) is an active regimen in patients with multiple myeloma and has been used in few patients with amyloidosis. Here, ...
Pilot study of pegylated interf ...
The role of the Epstein–Barr virus (EBV) in the pathogenesis of extranodal natural killer/T-cell lymphoma (ENKTCL), and its resistance to chemothera ...
The metalloprotease, NN-PF3 fro ...
NN-PF3 is a non-toxic, anticoagulant, highmolecular- mass (67.81 kDa) metalloprotease from Indian cobra (Naja naja) venom. In the present study, NN- ...
Proteasome inhibitor bortezomib ...
Endothelial cells have special relevance in tumor progression. Here, we investigated the effect of the proteasome inhibitor bortezomib on tumor–endo ...
Lenalidomide in combination wit ...
Over the past decade, treatment options for patients with multiple myeloma (MM) have improved substantially, resulting in better response rates and ...
Long-term outcomes of HLA-match ...
Allogeneic hematopoetic stem cell transplantation (allo-HSCT) remains the only curative therapy for chronic myelogenous leukemia (CML). In this stud ...
A modified regimen of pegylated ...
Preclinical and clinical studies have demonstrated synergy between bortezomib and pegylated liposomal doxorubicin (PLD) for relapsed/refractory (R/ ...
Gemcitabine and vinorelbine com ...
We investigated the efficacy of gemcitabine and vinorelbine (Gem/Vin) combination chemotherapy as a salvage and mobilization regimen in relapsed or ...
Hematopoietic stem cell mobiliz ...
Recent developments in the field of targeted therapy have led to the discovery of a new drug, plerixafor, that is a specific inhibitor of the CXCR4 ...
Characteristics of BCR–ABL kina ...
To explore the characteristics of BCR–ABL kinase domain point mutations in Chinese chronic myeloid leukemia (CML) patients, a cohort of 127 patients ...